Icon

DUEXIS (nda022519)- (26.6MG;800MG)

FAMOTIDINE; IBUPROFEN HORIZON
26.6MG;800MG
Yes Yes
2026-Jul-18 Expired
None None
None No
DUEXIS, a combination of a nonsteroidal anti-inflammatory drug (NSAID) ibuprofen and the histamine H2-receptor antagonist famotidine, is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, which in the clinical trials was defined as a gastric and/or duodenal ulcer, in patients who are taking ibuprofen for those indications.
5 0 4
Total Other Developers 20
Drugs with Suitability No
26.6MG;800MG ** ** Up - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** **** *** ***** ************ ******* *********** **** **. ***, ******* ****** ***** *****, *******, ******, *****, ***** & *** ******, ***** (***) ***
****** ****** ****** *** ****** *************** *** *********** *** * ********** **, ******* *****, *** **** (**) *****, ****** ****** (***) ***
****** **** ********** *** ************ ******* ******* *********** */***, **********-******** **** ****, **********, ***********,,, *******, ***** **** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.